Cornerstone Therapeutics profit falls on expenses – BusinessWeek

Cornerstone Therapeutics profit falls on expenses
BusinessWeek
Sales of the asthma treatment Zyflo CR and Zyflo doubled to $8.8 million. For the full year, the company earned $6.2 million or 24 cents per share, down from $10.2 million, or 54 cents per share, in 2009. Revenue rose to $125.3 million from $109.6
Critical Therapeutics Inc. Reports Operating Results (10-K)GuruFocus.com

all 6 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.